–News Direct– Trident Royalties PLC (AIM:TRR, OTCQX:TDTRF) CEO Adam Davidson joined Proactive's Stephen Gunnion with details of the company's performance for the quarter ended 31…
View More Trident Royalties reports strong quarterly performance and strategic asset developmentsAclara Resources awards Carina Module pre-feasibility study to Hatch
–News Direct– Aclara Resources Inc (TSX:ARA, OTC:ARAAF) chief operating officer Barry Murphy joined Proactive's Stephen Gunnion with news that the company has contracted global multidisciplinary…
View More Aclara Resources awards Carina Module pre-feasibility study to HatchWith The Cryptocurrency Market Historically Tumultuous, Regulated Futures Brokers Like EdgeClear May Offer More Security Than Their Spot Counterparts
–News Direct– By Austin DeNoce, Benzinga The cryptocurrency market has been a rollercoaster of innovation and growth, but it's not without its share of pitfalls.…
View More With The Cryptocurrency Market Historically Tumultuous, Regulated Futures Brokers Like EdgeClear May Offer More Security Than Their Spot CounterpartsRC365 Holding CEO Michael Law discusses rapid growth and future plans
–News Direct– RC365 Holding PLC (LSE:RCGH) has made significant progress in 2024, according to CEO Michael Law, in an interview with Proactive's Stephen Gunnion. The…
View More RC365 Holding CEO Michael Law discusses rapid growth and future plansPoolbeg Pharma’s POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
–News Direct– Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) chief legal officer John McEvoy joins Proactive's Stephen Gunnion with news that POLB 001's Immuno-modulator II has received…
View More Poolbeg Pharma’s POLB 001 immuno-modulator II receives fully-granted patent from US Patent OfficeFaron Pharmaceuticals’ new CEO Dr Juho Jalkanen sets bold vision for 2024
–News Direct– Faron Pharmaceuticals Limited (AIM:FARN) new CEO Dr Juho Jalkanen joined Proactive's Stephen Gunnion with his vision for the company. The founding member and…
View More Faron Pharmaceuticals’ new CEO Dr Juho Jalkanen sets bold vision for 2024Iofina’s strategic success: revenue surpasses $50 million, expansion underway
–News Direct– Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker takes Proactive's Stephen Gunnion through the company's 2023 full-year performance, which marked another record. Iofina…
View More Iofina’s strategic success: revenue surpasses $50 million, expansion underwayElectric Guitar debuts on AIM with big plans following 3radical acquisition
–News Direct– Electric Guitar PLC (AIM:ELEG) CEO John Regan spoke to Proactive's Stephen Gunnion following the company's listing on London's AIM market following the reverse…
View More Electric Guitar debuts on AIM with big plans following 3radical acquisitionANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
–News Direct– ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen…
View More ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giantHIVE Digital Technologies CEO Aydin Kilic discusses strategic growth in AI and crypto mining
–News Direct– HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) president and CEO Aydin Kilic joined Stephen Gunnion in Proactive's London studio with insights into the companys transition…
View More HIVE Digital Technologies CEO Aydin Kilic discusses strategic growth in AI and crypto mining